Emtricitabine/TDF

NDC 72189-403 · Direct_Rx

Generic nameEmtricitabine/TDF

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE

Strength200; 300 mg/1; mg/1

Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]

Marketing categoryANDA

Packages

72189-403-03 — 3 TABLET, FILM COATED in 1 BOTTLE (72189-403-03)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69238-2095 — Emtricitabine and Tenofovir Disoproxil Fumarate, 70710-1364 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1365 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1366 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1367 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1620 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1621 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1622 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1709 — Emtricitabine and tenofovir disoproxil fumarate, 71205-776 — Emtricitabine and Tenofovir Disoproxil Fumarate, 71335-2364 — Tenofovir Disoproxil Fumarate, 71335-2650 — Emtricitabine and Tenofovir Disoproxil Fumarate, 71335-3155 — Tenofovir Disoproxil Fumarate, 71921-105 — Tenofovir Disoproxil Fumarate, 72162-2565 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 72189-312 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 72789-361 — Tenofovir Disoproxil Fumarate, 76282-677 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 82009-109 — Emtricitabine and Tenofovir Disoproxil Fumarate, 82804-086 — Emtricitabine and tenofovir disoproxil fumarate, +82 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.